Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.

Literature DB >> 2828027

Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.

H Shida¹, T Tochikura, T Sato, T Konno, K Hirayoshi, M Seki, Y Ito, M Hatanaka, Y Hinuma, M Sugimoto.

Abstract

The human T-lymphotropic virus type I (HTLV-I) is etiologically linked to adult T-cell leukemia (ATL). To develop a vaccine against ATL, we constructed recombinant vaccinia viruses containing the envelope gene of HTLV-I in the vaccinia virus hemagglutinin (HA) gene, a new site where foreign genes can be inserted. A single inoculation of the recombinant virus induced antibodies to the env proteins of HTLV-I in rabbits and had a protective effect against HTLV-I infection.

Entities: Chemical

Mesh：

Substances：

Year: 1987 PMID： 2828027 PMCID： PMC553794 DOI： 10.1002/j.1460-2075.1987.tb02660.x

Source DB: PubMed Journal: EMBO J ISSN： 0261-4189 Impact factor: 11.598

36 in total

1. RESCUE OF DERMOVACCINIA ABORTIVE INFECTION BY NEUROVACCINIA VIRUS IN L CELLS.

Authors: M ODA
Journal: Virology Date: 1965-04 Impact factor: 3.616

2. Recombinant vaccinia virus: immunization against multiple pathogens.

Authors: M E Perkus; A Piccini; B R Lipinskas; E Paoletti
Journal: Science Date: 1985-09-06 Impact factor: 47.728

3. Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.

Authors: T D Copeland; W P Tsai; Y D Kim; S Oroszlan
Journal: J Immunol Date: 1986-11-01 Impact factor: 5.422

4. Expression of human T-cell leukemia virus type I envelope protein in Saccharomyces cerevisiae.

Authors: T Kuga; S Hattori; M Yoshida; T Taniguchi
Journal: Gene Date: 1986 Impact factor: 3.688

5. Nucleotide sequence of the vaccinia virus hemagglutinin gene.

Authors: H Shida
Journal: Virology Date: 1986-04-30 Impact factor: 3.616

6. Insertion and deletion mutants of vaccinia virus.

Authors: M E Perkus; D Panicali; S Mercer; E Paoletti
Journal: Virology Date: 1986-07-30 Impact factor: 3.616

7. Type 1 human T-cell leukemia virus small envelope protein expressed in mouse cells by using a bovine papilloma virus-derived shuttle vector.

Authors: M Eiden; M Newman; A G Fisher; D L Mann; P M Howley; M S Reitz
Journal: Mol Cell Biol Date: 1985-11 Impact factor: 4.272

8. A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors: M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal: Gan Date: 1984-10

9. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

Authors: J W Yewdell; J R Bennink; G L Smith; B Moss
Journal: Proc Natl Acad Sci U S A Date: 1985-03 Impact factor: 11.205

10. Human T-cell leukemia virus type I: pseudotype neutralization of Japanese and American isolates with human and rabbit sera.

Authors: H Hoshino; P R Clapham; R A Weiss; I Miyoshi; M Yoshida; M Miwa
Journal: Int J Cancer Date: 1985-12-15 Impact factor: 7.396

32 in total

1. Recombinant vaccinia viruses. Design, generation, and isolation.

Authors: C C Broder; P L Earl
Journal: Mol Biotechnol Date: 1999-12-15 Impact factor: 2.695

2. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.

Authors: K G Hadlock; J Rowe; S Perkins; P Bradshaw; G Y Song; C Cheng; J Yang; R Gascon; J Halmos; S M Rehman; M S McGrath; S K Foung
Journal: J Virol Date: 1997-08 Impact factor: 5.103

3. Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses.

Authors: S Funahashi; S Itamura; H Iinuma; K Nerome; M Sugimoto; H Shida
Journal: J Virol Date: 1991-10 Impact factor: 5.103

4. Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease.

Authors: S H Nam; M Kidokoro; H Shida; M Hatanaka
Journal: J Virol Date: 1988-10 Impact factor: 5.103

5. Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells.

Authors: Y Hakata; M Yamada; H Shida
Journal: J Virol Date: 2001-12 Impact factor: 5.103

6. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.

Authors: K Furukawa; M Mori; N Ohta; H Ikeda; H Shida; K Furukawa; H Shiku
Journal: J Clin Invest Date: 1994-11 Impact factor: 14.808

7. The native form and maturation process of hepatitis C virus core protein.

Authors: K Yasui; T Wakita; K Tsukiyama-Kohara; S I Funahashi; M Ichikawa; T Kajita; D Moradpour; J R Wands; M Kohara
Journal: J Virol Date: 1998-07 Impact factor: 5.103

8. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.

Authors: H Shida; Y Hinuma; M Hatanaka; M Morita; M Kidokoro; K Suzuki; T Maruyama; F Takahashi-Nishimaki; M Sugimoto; R Kitamura
Journal: J Virol Date: 1988-12 Impact factor: 5.103

9. Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression.

Authors: N Y Jin; S Funahashi; H Shida
Journal: Arch Virol Date: 1994 Impact factor: 2.574

10. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.

Authors: Y Sagara; Y Inoue; H Shiraki; A Jinno; H Hoshino; Y Maeda
Journal: J Virol Date: 1996-03 Impact factor: 5.103